Cargando…
Dysbiosis and Intestinal Barrier Dysfunction in Pediatric Congenital Heart Disease Is Exacerbated Following Cardiopulmonary Bypass
There are no data evaluating the microbiome in congenital heart disease following cardiopulmonary bypass. The authors evaluated patients with congenital heart disease undergoing cardiopulmonary bypass and noncardiac patients undergoing surgery without bypass. Patients with congenital heart disease h...
Autores principales: | Salomon, Jeffrey, Ericsson, Aaron, Price, Amber, Manithody, Chandrashekhara, Murry, Daryl J., Chhonker, Yashpal S., Buchanan, Paula, Lindsey, Merry L., Singh, Amar B., Jain, Ajay K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093480/ https://www.ncbi.nlm.nih.gov/pubmed/33997519 http://dx.doi.org/10.1016/j.jacbts.2020.12.012 |
Ejemplares similares
-
Piglet cardiopulmonary bypass induces intestinal dysbiosis and barrier dysfunction associated with systemic inflammation
por: Salomon, Jeffrey D., et al.
Publicado: (2023) -
LC–MS/MS method for simultaneous determination of diethylcarbamazine, albendazole and albendazole metabolites in human plasma: Application to a clinical pharmacokinetic study
por: Chhonker, Yashpal S., et al.
Publicado: (2018) -
ZIP8-Mediated Intestinal Dysbiosis Impairs Pulmonary Host Defense against Bacterial Pneumonia
por: Samuelson, Derrick R., et al.
Publicado: (2022) -
Simultaneous Quantitation of Lipid Biomarkers for Inflammatory Bowel Disease Using LC–MS/MS
por: Chhonker, Yashpal S., et al.
Publicado: (2021) -
Simultaneous Quantitation of S(+)- and R(−)-Baclofen and Its Metabolite in Human Plasma and Cerebrospinal Fluid using LC–APCI–MS/MS: An Application for Clinical Studies
por: He, Qingfeng, et al.
Publicado: (2020)